636 A Phase 1, Open-Label, Dose Escalation and Expansion Study of CUE-102 Monotherapy in HLA-A*0201 Positive Patients with WT1-positive Recurrent/metastatic Cancers
JOURNAL FOR IMMUNOTHERAPY OF CANCER(2022)
关键词
Tumor Regression,Cancer Immunotherapy,Intratumor Heterogeneity
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要